Real-time enrollment status for this bipolar i disorder clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 7:02 PM UTC
| NCT Number | NCT04777357 |
| Recruiting Status | Recruiting |
| Condition | Bipolar I Disorder |
| Phase | PHASE3 |
| Target Enrollment | 380 participants |
| Active Locations | 69 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | July 27, 2026 (Jul 27, 2026) |
As of August 31, 2026: Clinical trial NCT04777357 is currently recruiting participants. This phase3 study for bipolar i disorder is actively seeking new participants at 69 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04777357 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 69 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04777357 was last updated Jul 27, 2026 (July 27, 2026). HelloStudys verifies this status automatically.